Azenta Life Sciences

Azenta Life Sciences is a global provider of life sciences solutions, focusing on genomics, cryogenic storage, automation, and informatics. The company offers reliable cold-chain sample management solutions and genomic services to support drug development, clinical research, and advanced cell therapies. Azenta serves top pharmaceutical, biotech, academic, and healthcare institutions worldwide, enabling faster breakthroughs and therapies to market.

Herman Cueto

Executive Vice President and CFO

4 past transactions

Ziath

Acquisition in 2023
Ziath is a manufacturer focused on developing and producing advanced 2D barcode readers designed to decode datamatrix barcodes on sample tubes used in laboratories across the United Kingdom. The company offers a range of products, including barcode scanners and accompanying software management tools to facilitate efficient sample tracking and data management. By providing state-of-the-art technology, Ziath enhances laboratory operations, ensuring accuracy and reliability in sample identification.

B Medical Systems

Acquisition in 2022
B Medical Systems is a manufacturer and global distributor based in Luxembourg, specializing in medical refrigeration, blood management, and vaccine cold chain equipment. With over 35 years of experience, the company develops innovative technologies that are essential for safely storing, transporting, and handling temperature-sensitive materials, including medicines, blood, vaccines, and biospecimens. Its product portfolio features vaccine transport systems equipped with real-time monitoring solutions, medical refrigeration devices capable of operating at various temperature levels, and comprehensive blood management solutions. B Medical Systems serves a wide clientele, including hospitals, pharmacies, laboratories, and governmental health organizations, ensuring reliable and certified medical devices that come with a low cost of ownership. The company leverages a global network of over 150 partners to deliver prompt assistance, even in remote locations, thereby supporting health institutions and non-governmental organizations in their mission to save lives and enhance community well-being.

Barkey

Acquisition in 2022
Barkey Holding is a manufacturer of medical devices specializing in innovative warming and thawing technologies. The company provides essential equipment for anesthesia, blood banks, intensive care units, operating theatres, and recovery rooms. Among its key products is the Barkey plasmatherm, a dry thawing device designed for blood and blood products as well as various cell materials, including CAR-T cells. The plasmatherm is engineered to ensure consistent and even thawing, which promotes high cell viability. Barkey serves a diverse range of clients, including hospitals, biotechnology firms, life science organizations, and pharmaceutical companies, contributing significantly to improving patient care and safety in medical settings.

Trans-Hit Biomarkers

Acquisition in 2020
Trans-Hit Biomarkers Inc. is a biospecimen procurement contract research organization based in Laval, Canada, founded in 2009. The company specializes in providing access to a diverse network of academic, hospital, and clinical sources for the collection of biospecimens and clinical samples. By leveraging partnerships with state-of-the-art academic biorepositories and clinical sites, Trans-Hit Biomarkers supports the biotechnology industry in conducting research and development. In December 2020, the company became a subsidiary of Brooks Life Science Systems, further enhancing its capabilities in the field of biospecimen procurement.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.